Global Trust Asset Management LLC cut its holdings in McKesson Co. (NYSE:MCK – Free Report) by 0.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,289 shares of the company’s stock after selling 30 shares during the period. McKesson makes up 1.0% of Global Trust Asset Management LLC’s portfolio, making the stock its 23rd largest position. Global Trust Asset Management LLC’s holdings in McKesson were worth $2,615,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in MCK. Swedbank AB bought a new stake in McKesson in the first quarter worth $669,326,000. International Assets Investment Management LLC raised its stake in shares of McKesson by 1,020.2% during the third quarter. International Assets Investment Management LLC now owns 806,878 shares of the company’s stock valued at $398,937,000 after acquiring an additional 734,849 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of McKesson by 3,621.7% during the first quarter. Bessemer Group Inc. now owns 349,395 shares of the company’s stock valued at $187,572,000 after acquiring an additional 340,007 shares during the last quarter. Bristol Gate Capital Partners Inc. bought a new position in shares of McKesson during the first quarter valued at about $97,510,000. Finally, Assenagon Asset Management S.A. raised its stake in shares of McKesson by 581.0% during the third quarter. Assenagon Asset Management S.A. now owns 151,240 shares of the company’s stock valued at $74,776,000 after acquiring an additional 129,031 shares during the last quarter. 85.07% of the stock is owned by institutional investors.
McKesson Stock Up 0.6 %
NYSE MCK opened at $504.96 on Friday. The firm has a market cap of $65.61 billion, a PE ratio of 22.56, a price-to-earnings-growth ratio of 1.17 and a beta of 0.44. The company has a 50 day moving average price of $518.29 and a 200 day moving average price of $551.37. McKesson Co. has a 52 week low of $431.35 and a 52 week high of $637.51.
McKesson Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were issued a $0.71 dividend. This is an increase from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 annualized dividend and a dividend yield of 0.56%. The ex-dividend date was Friday, August 30th. McKesson’s dividend payout ratio is 12.69%.
Analyst Upgrades and Downgrades
MCK has been the subject of several recent analyst reports. Evercore ISI lowered their price objective on shares of McKesson from $660.00 to $630.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Wells Fargo & Company decreased their price target on shares of McKesson from $576.00 to $535.00 and set an “equal weight” rating for the company in a research note on Friday, September 13th. Leerink Partners decreased their price target on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a research note on Monday, October 7th. JPMorgan Chase & Co. increased their price target on shares of McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. Finally, Robert W. Baird reissued a “neutral” rating and issued a $531.00 price target (down from $603.00) on shares of McKesson in a research note on Tuesday, September 24th. Five investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and an average target price of $610.86.
Get Our Latest Analysis on MCK
Insider Activity
In other news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $561.10, for a total value of $2,105,808.30. Following the sale, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at $44,094,604.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.11% of the company’s stock.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
See Also
- Five stocks we like better than McKesson
- The Significance of Brokerage Rankings in Stock Selection
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Quiet Period Expirations Explained
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How to Plot Fibonacci Price Inflection Levels
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.